{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:28:29Z","timestamp":1790011709374,"version":"4.0.1"},"reference-count":99,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Female BRCA1\/2 pathogenic variant carriers have an increased lifetime risk for breast and ovarian cancer. Cancer-unaffected women who are newly diagnosed with this pathogenic variant may experience psychological distress because of imminent health threat. No comprehensible review on psychological morbidity in cancer-unaffected BRCA1\/2 pathogenic variant carriers is currently available. This review aims to give an overview about all available the studies in which psychological outcomes have been assessed in cancer-unaffected BRCA1\/2 pathogenic variant carriers, whether as a primary outcome or secondary measurement. A systematic search across four databases (Web of Science, PubMed, ScienceDirect, and EBSCO) was conducted. Studies had to report on cancer-unaffected pathogenic variant carriers (exclusively or separately) and use a validated measure of psychological morbidity to be eligible. Measures were only included if they were used in at least three studies. The final review consisted of 45 studies from 13 countries. Distress measures, including anxiety and cancer worry, were most often assessed. Most studies found a peak of distress immediately after genetic test result disclosure, with a subsequent decline over the following months. Only some studies found elevated distress in carriers compared to non-carriers in longer follow-ups. Depression was frequently investigated but largely not found to be of clinical significance. Quality of life seemed to be largely unaffected by a positive genetic test result, although there was some evidence that younger women, especially, were less satisfied with their role functioning in life. Body image has been infrequently assessed so far, but the evidence suggested that there may be a decrease in body image after genetic test result disclosure that may decrease further for women who opt for a prophylactic mastectomy. Across all the outcomes, various versions of instruments were used, often limiting the comparability among the studies. Hence, future research should consider using frequently used instruments, as outlined by this review. Finally, while many studies included cancer-unaffected carriers, they were often not reported on separately, which made it difficult to draw specific conclusions about this population.<\/jats:p>","DOI":"10.3390\/curroncol30040274","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T04:31:21Z","timestamp":1679891481000},"page":"3590-3608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessing Psychological Morbidity in Cancer-Unaffected BRCA1\/2 Pathogenic Variant Carriers: A Systematic Review"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-5716","authenticated-orcid":false,"given":"Anna","family":"Isselhard","sequence":"first","affiliation":[{"name":"Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00eb","family":"Lautz","sequence":"additional","affiliation":[{"name":"Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-5657","authenticated-orcid":false,"given":"Kerstin","family":"Rhiem","sequence":"additional","affiliation":[{"name":"Center for Hereditary Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Medical Faculty, University Hospital, 50937 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1726-9300","authenticated-orcid":false,"given":"Stephanie","family":"Stock","sequence":"additional","affiliation":[{"name":"Institute of Health Economics and Clinical Epidemiology, University Hospital Cologne, 50935 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Friedenson, B. (2007). The BRCA1\/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-152"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1471-4914(02)02434-6","article-title":"The relationship between the roles of BRCA genes in DNA repair and cancer predisposition","volume":"8","author":"Tutt","year":"2002","journal-title":"Trends Mol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-0004.2008.01146.x","article-title":"Comparison of proactive and usual approaches to offering predictive testing for BRCA1\/2 mutations in unaffected relatives","volume":"75","author":"Evans","year":"2009","journal-title":"Clin. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrc1301","article-title":"Genetic testing for cancer susceptibility: The promise and the pitfalls","volume":"4","author":"Lerman","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-019-05152-9","article-title":"High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer","volume":"175","author":"Bick","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: A prospective analysis","volume":"24","author":"Jager","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","article-title":"Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers","volume":"177","author":"Jager","year":"2019","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ejca.2011.10.020","article-title":"Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: A prospective long-term follow-up study","volume":"48","author":"Seynaeve","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/jama.2018.18942","article-title":"Risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers: A complex discussion","volume":"321","author":"Domchek","year":"2019","journal-title":"JAMA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.breast.2016.05.012","article-title":"Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy\u2014A review of the literature","volume":"28","author":"Glassey","year":"2016","journal-title":"Breast"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1524-4741.2007.00521.x","article-title":"Positive, negative, and disparate\u2014Women\u2019s differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy","volume":"14","author":"Altschuler","year":"2008","journal-title":"Breast J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10549-014-2931-9","article-title":"MRI breast screening in high-risk women: Cancer detection and survival analysis","volume":"145","author":"Evans","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1177\/1049732314529666","article-title":"The Genetic Testing Experience of BRCA-Positive Women: Deciding Between Surveillance and Surgery","volume":"24","year":"2014","journal-title":"Qual. Health Res."},{"key":"ref_16","first-page":"543","article-title":"BRCA carriers, prophylactic salpingo-oophorectomy and menopause: Clinical management considerations and recommendations","volume":"8","author":"Finch","year":"2012","journal-title":"Women\u2019s Health"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Marchetti, C., de Felice, F., Palaia, I., Perniola, G., Musella, A., Musio, D., Muzii, L., Tombolini, V., and Panici, P.B. (2014). Risk-reducing salpingo-oophorectomy: A meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Women\u2019s Health, 14.","DOI":"10.1186\/s12905-014-0150-5"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.clbc.2018.09.011","article-title":"Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review","volume":"19","author":"Xiao","year":"2019","journal-title":"Clin. Breast Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10897-009-9267-3","article-title":"Women\u2019s perceptions of the personal and family impact of genetic cancer risk assessment: Focus group findings","volume":"19","author":"MacDonald","year":"2010","journal-title":"J. Genet. Counsel."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s00520-019-04918-7","article-title":"Psychological aspects, risk and protective factors related to BRCA genetic testing: A review of the literature","volume":"27","author":"Lombardi","year":"2019","journal-title":"Support Care Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.socscimed.2016.06.039","article-title":"\u201cIt\u2019s not if I get cancer, it\u2019s when I get cancer\u201d: BRCA-positive patients\u2019(un) certain health experiences regarding hereditary breast and ovarian cancer risk","volume":"163","author":"Dean","year":"2016","journal-title":"Soc. Sci. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/1049732319885113","article-title":"BRCA and Motherhood: A Matter of Time and Timing","volume":"30","author":"Possick","year":"2019","journal-title":"Qual. Health Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pon.4558","article-title":"Perceived influence of psychological consultation on psychological well-being, body image, and intimacy following bilateral prophylactic mastectomy: A qualitative analysis","volume":"27","author":"Glassey","year":"2018","journal-title":"Psycho.-Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s10897-009-9232-1","article-title":"The Effect of BRCA Gene Testing on Family Relationships: A Thematic Analysis of Qualitative Interviews","volume":"18","author":"Douglas","year":"2009","journal-title":"J. Genet. Counsel."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pon.933","article-title":"Psychological impact of genetic testing for cancer susceptibility: An update of the literature","volume":"14","author":"Meiser","year":"2005","journal-title":"Psycho.-Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0014778","article-title":"Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review","volume":"28","author":"Hamilton","year":"2009","journal-title":"Health Psychol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1055-9965.EPI-09-0548","article-title":"Randomized Controlled Trial of a Psychosocial Telephone Counseling Intervention in BRCA1 and BRCA2 Mutation Carriers","volume":"19","author":"Graves","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Boghosian, T., McCuaig, J.M., Carlsson, L., and Metcalfe, K.A. (2021). Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review. Cancers, 13.","DOI":"10.3390\/cancers13071486"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jeffers, L., Reid, J., Fitzsimons, D., Morrison, P.J., and Dempster, M. (2019). Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery. Cochrane Database Syst. Rev., 10.","DOI":"10.1002\/14651858.CD012894.pub2"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s10897-016-9949-6","article-title":"Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1\/2 Mutation Carriers: A Systematic Review","volume":"25","author":"Ringwald","year":"2016","journal-title":"J. Genet. Counsel."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.maturitas.2011.08.001","article-title":"Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: A review","volume":"70","author":"Finch","year":"2011","journal-title":"Maturitas"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kautz-Freimuth, S., Reda\u00e8lli, M., Rhiem, K., Vodermaier, A., Krassuski, L., Nicolai, K., Schnepper, M., Kuboth, V., Dick, J., and Vennedey, V. (2021). Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making. BMC Med. Inform. Decis. Mak., 21.","DOI":"10.1186\/s12911-021-01528-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1590\/S0104-11692007000300023","article-title":"The PICO strategy for the research question construction and evidence search","volume":"15","author":"Nobre","year":"2007","journal-title":"Rev. Lat. Am. Enferm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Janati","year":"2020","journal-title":"Emerg. Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e011458","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes","year":"2016","journal-title":"BMJ Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/cge.12298","article-title":"The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers","volume":"85","author":"Borreani","year":"2014","journal-title":"Clin. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Brand, H., Speiser, D., Besch, L., Roseman, J., and Kendel, F. (2021). Making Sense of a Health Threat: Illness Representations, Coping, and Psychological Distress among BRCA1\/2 Mutation Carriers. Genes, 12.","DOI":"10.3390\/genes12050741"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-016-9981-6","article-title":"Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation","volume":"26","author":"Buchanan","year":"2017","journal-title":"J. Genet. Counsel."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1037\/a0032737","article-title":"Characterizing biased cancer-related cognitive processing: Relationships with BRCA1\/2 genetic mutation status, personal cancer history, age, and prophylactic surgery","volume":"33","author":"Carpenter","year":"2014","journal-title":"Health Psychol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10897-005-1371-4","article-title":"Predictive Genetic Testing for Hereditary Breast and Ovarian Cancer: Psychological Distress and Illness Representations 1 Year Following Disclosure","volume":"14","author":"Claes","year":"2005","journal-title":"J. Genet. Counsel."},{"key":"ref_42","first-page":"63","article-title":"Psychological Responses to BRCA1 Mutation Testing: Preliminary Findings","volume":"16","author":"Croyle","year":"1997","journal-title":"Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1300\/J077v22n03_05","article-title":"BRCA1\/2 Mutation Carriers","volume":"22","author":"Dagan","year":"2004","journal-title":"J. Psychosoc. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ypmed.2008.11.007","article-title":"Quality of life in asymptomatic BRCA1\/2 mutation carriers","volume":"48","author":"Dagan","year":"2009","journal-title":"Prev. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2466\/pr0.98.3.873-881","article-title":"Using the Impact of Event Scale to Evaluate Distress in the Context of Genetic Testing for Breast Cancer Susceptibility","volume":"98","author":"Dorval","year":"2006","journal-title":"Psychol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/gtmb.2008.0126","article-title":"Identification of Patients at High Risk of Psychological Distress After BRCA1 Genetic Testing","volume":"13","author":"Metcalfe","year":"2009","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pon.2041","article-title":"The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation","volume":"22","author":"Finch","year":"2013","journal-title":"Psycho-Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.bjc.6603610","article-title":"Predictive genetic testing for BRCA1\/2 in a UK clinical cohort: Three-year follow-up","volume":"96","author":"Foster","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/pon.1198","article-title":"The relationship between coping strategies and anxiety in women from families with familial breast\u2013ovarian cancer in the absence of demonstrated mutations","volume":"17","author":"Geirdal","year":"2008","journal-title":"Psycho-Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10689-004-7995-y","article-title":"Psychological distress in women at risk of hereditary breast\/ovarian or HNPCC cancers in the absence of demonstrated mutations","volume":"4","author":"Geirdal","year":"2005","journal-title":"Fam. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10689-012-9588-5","article-title":"Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer","volume":"12","author":"Gopie","year":"2013","journal-title":"Fam. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/1055-9965.EPI-11-0991","article-title":"Long-Term Psychosocial Outcomes of BRCA1\/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery Choice","volume":"21","author":"Graves","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bjps.2007.08.006","article-title":"Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction","volume":"61","author":"Isern","year":"2008","journal-title":"J. Plast. Reconstr. Aesthetic Surg."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Isselhard, A., Lautz, Z., T\u00f6pper, M., Rhiem, K., Schmutzler, R., Vitinius, F., Fischer, H., Berger-H\u00f6ger, B., Steckelberg, A., and Beifus, K. (2023). Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure: Results from Cancer-Unaffected BRCA1\/2 Mutation Carriers. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20031684"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e3181f48d1c","article-title":"Time to prophylactic surgery in BRCA1\/2 carriers depends on psychological and other characteristics","volume":"12","author":"Bouhnik","year":"2010","journal-title":"Genet. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/cncr.21479","article-title":"The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation","volume":"104","author":"Kinney","year":"2005","journal-title":"Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pon.3703","article-title":"Randomized controlled trial of Inquiry-Based Stress Reduction (IBSR) technique for BRCA1\/2 mutation carriers","volume":"24","author":"Landau","year":"2015","journal-title":"Psycho-Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10689-013-9621-3","article-title":"Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?","volume":"12","author":"Lapointe","year":"2013","journal-title":"Fam. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/1096-8628(20010101)98:1<15::AID-AJMG1014>3.0.CO;2-0","article-title":"Psychological impact of receiving a BRCA1\/BRCA2 test result","volume":"98","author":"Lodder","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1015269620265","article-title":"One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)","volume":"73","author":"Lodder","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12160-007-9004-9","article-title":"Benefit Finding in Response to BRCA1\/2 Testing","volume":"35","author":"Low","year":"2008","journal-title":"Ann. Behav. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.2006.07.4922","article-title":"Predictors of Prophylactic Bilateral Salpingo-Oophorectomy Compared With Gynecologic Screening Use in BRCA1\/2 Mutation Carriers","volume":"25","author":"Madalinska","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10689-012-9512-z","article-title":"French women\u2019s breast self-examination practices with time after undergoing BRCA1\/2 genetic testing","volume":"11","author":"Maheu","year":"2012","journal-title":"Fam. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/pon.3435","article-title":"Which factors predict proposal and uptake of psychological counselling after BRCA1\/2 test result disclosure?","volume":"23","author":"Maheu","year":"2014","journal-title":"Psycho-Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0959-8049(02)00264-2","article-title":"Psychological impact of genetic testing in women from high-risk breast cancer families","volume":"38","author":"Meiser","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s10549-011-1941-0","article-title":"Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening","volume":"133","author":"Metcalfe","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/gim.2016.108","article-title":"Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: A multisite, randomized, controlled trial","volume":"19","author":"Metcalfe","year":"2017","journal-title":"Genet. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41416-020-0861-3","article-title":"Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: An international analysis","volume":"123","author":"Metcalfe","year":"2020","journal-title":"British J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-008-0140-0","article-title":"Psychological impact of recall in high-risk breast MRI screening","volume":"115","author":"Rubinstein","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/B:FAME.0000026820.32469.4a","article-title":"BRCA1 testing with definitive results: A prospective study of psychological distress in a large clinic-based sample","volume":"3","author":"Reichelt","year":"2004","journal-title":"Fam. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10689-008-9182-z","article-title":"Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast\/ovarian cancer","volume":"7","author":"Reichelt","year":"2008","journal-title":"Fam. Cancer"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.2002.20.2.514","article-title":"Impact of BRCA1\/BRCA2 Mutation Testing on Psychologic Distress in a Clinic-Based Sample","volume":"20","author":"Schwartz","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2869.2009.00805.x","article-title":"Sleep disturbances in asymptomatic BRCA1\/2 mutation carriers: Women at high risk for breast\u2013ovarian cancer","volume":"19","author":"Shochat","year":"2010","journal-title":"J. Sleep Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/pon.1291","article-title":"Psychological distress and quality of life associated with genetic testing for breast cancer risk","volume":"17","author":"Smith","year":"2008","journal-title":"Psycho-Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.breast.2011.04.004","article-title":"Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance","volume":"20","author":"Spiegel","year":"2011","journal-title":"Breast"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1200\/JCO.2005.03.7259","article-title":"Clinical Characteristics Affect the Impact of an Uninformative DNA Test Result: The Course of Worry and Distress Experienced by Women Who Apply for Genetic Testing for Breast Cancer","volume":"24","author":"Timmermans","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s12282-019-01033-7","article-title":"Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers","volume":"27","author":"Apon","year":"2020","journal-title":"Breast Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1200\/JCO.2003.10.100","article-title":"Long-Term Psychological Impact of Carrying a BRCA1\/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study","volume":"21","author":"Lodder","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/pon.1178","article-title":"The common sense model of self-regulation and psychological adjustment to predictive genetic testing: A prospective study","volume":"16","author":"Duivenvoorden","year":"2007","journal-title":"Psycho-Oncol."},{"key":"ref_80","first-page":"346","article-title":"Impact of BRCA1\/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer","volume":"124","author":"Stalmeier","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/sj.bjc.6602207","article-title":"Psychosocial impact of breast\/ovarian (BRCA 1\/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort","volume":"91","author":"Watson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","article-title":"Impact of Event Scale: A measure of subjective stress","volume":"41","author":"Horowitz","year":"1979","journal-title":"Psychosom. Med."},{"key":"ref_83","unstructured":"Weiss, D.S. (2007). Cross-Cultural Assessment of Psychological Trauma and PTSD, Springer."},{"key":"ref_84","unstructured":"Snaith, P., and Zigmond, A.S. (2000). Handbook of Psychiatric Measures, American Psychiatric Association."},{"key":"ref_85","first-page":"259","article-title":"Psychological side effects of breast cancer screening","volume":"10","author":"Lerman","year":"1991","journal-title":"Health Psychol. Off. J. Div. Health Psychol. Am. Psychol. Assoc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1200\/JCO.1994.12.4.843","article-title":"Attitudes about genetic testing for breast-ovarian cancer susceptibility","volume":"12","author":"Lerman","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"ref_87","first-page":"3","article-title":"The State-Trait Anxiety Inventory","volume":"5","author":"Spielberger","year":"1971","journal-title":"Interam. J. Psychol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The Brief Symptom Inventory: An introductory report","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0033291700021644","article-title":"A scaled version of the General Health Questionnaire","volume":"9","author":"Goldberg","year":"1979","journal-title":"Psychol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1037\/h0037562","article-title":"The measurement of pessimism: The Hopelessness Scale","volume":"42","author":"Beck","year":"1974","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1207\/s15327752jpa6403_9","article-title":"The Measurement Structure of the Center for Epidemiologic Studies Depression Scale","volume":"64","author":"Sheehan","year":"1995","journal-title":"J. Personal. Assess."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity","volume":"34","author":"Ware","year":"1996","journal-title":"Med. Care"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/0959-8049(92)90068-D","article-title":"The assessment of sexual function in cancer patients","volume":"28","author":"Cull","year":"1992","journal-title":"Eur. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/humrep\/des441","article-title":"Reproductive decision-making in young female carriers of a BRCA mutation","volume":"28","author":"Donnelly","year":"2013","journal-title":"Hum. Reprod."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jmwh.2006.07.002","article-title":"Body Image After Bilateral Prophylactic Mastectomy: An Integrative Literature Review","volume":"51","author":"McGaughey","year":"2006","journal-title":"J. Midwifery Women\u2019s Health"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.3389\/fpsyg.2021.778484","article-title":"Body Image in BRCA-Positive Young Women Following Bilateral Risk-Reducing Mastectomy: A Review of the Literature","volume":"12","author":"Torrisi","year":"2021","journal-title":"Front. Psychol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.sxmr.2019.11.003","article-title":"Sexual Health in the Era of Cancer Genetic Testing: A Systematic Review","volume":"8","author":"Yusufov","year":"2020","journal-title":"Sex. Med. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-Cancer Risk in Families with Mutations in PALB2","volume":"371","author":"Antoniou","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/274\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:03:00Z","timestamp":1760122980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/4\/274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":99,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["curroncol30040274"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30040274","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]}}}